Guoyin Kai

6.9k citations
154 papers · 5.3k indexed · h-index 41

Guoyin Kai

145 papers receiving 5.1k citations

Peers

Guoyin Kai
Comparison fields: 5 of 127
  • Biochemistry 723
  • Complementary and alternative medicine 803
  • Biotechnology 559
  • Molecular Biology 3.7k
  • Pharmacology 746
Replace Lie‐Fen Shyur with:
Lie‐Fen Shyur Taiwan
Yumiko Kimura Japan
Seikou Nakamura Japan
Junei Kinjo Japan
Yoshiyuki Mizushina Japan
Erdal Bedi̇r Türkiye
Phan Văn Kiệm Vietnam
Yew‐Min Tzeng Taiwan
Motohiko Ukiya Japan
Hideaki Otsuka Japan
Guoyin Kai relative to Lie‐Fen Shyur Taiwan Lie‐Fen Shyur's profile →
Citations per field
00.5×3.7×
Lie‐Fen Shyur · 1×
Citations per year

Countries citing papers authored by Guoyin Kai

Since Specialization
Citations

This map shows the geographic impact of Guoyin Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoyin Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoyin Kai more than expected).

Fields of papers citing papers by Guoyin Kai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoyin Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoyin Kai. The network helps show where Guoyin Kai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guoyin Kai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guoyin Kai Line = papers co-authored together Guoyin Kai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20251
5 20243
6 20240
7 20242
8 20240
9 20243
10 20248
11 20234
12 202325
13 20235
14 202314
15 202152
16 202010
17
Effect of Three Plant Hormone Elicitors on the Camptothecin Accumulation and Gene Transcript Profiling in Camptotheca Acuminata Seedlings
201411
18 201245
19 20119
20 201177

About Guoyin Kai

Guoyin Kai is a scholar working on Complementary and alternative medicine, Biochemistry and Molecular Biology, having authored 154 papers that have together received 5.3k indexed citations. Recurring topics across this work include Plant biochemistry and biosynthesis (57 papers), Plant Gene Expression Analysis (33 papers), Plant tissue culture and regeneration (30 papers), Traditional Chinese Medicine Analysis (22 papers), Microbial Natural Products and Biosynthesis (16 papers), Photosynthetic Processes and Mechanisms (11 papers), Phytochemicals and Antioxidant Activities (11 papers) and Cancer therapeutics and mechanisms (10 papers). The work is most often cited by research in Biochemistry (723 citations), Complementary and alternative medicine (803 citations) and Biotechnology (559 citations). Guoyin Kai has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianbo Xiao, Min Shi, Xiaohong Chen, Xiaoling Ni, Wei Zhou, Pan Liao, Koichiro Yamamoto, Xiuqin Luo, Lijie Cui and Xiaolong Hao. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026